相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Roles of Prostaglandin E2-EP3/EP4 Receptor Signaling in the Enhancement of Lymphangiogenesis During Fibroblast Growth Factor-2-Induced Granulation Formation
Kanako Hosono et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Differential Regulation of the Aggressive Phenotype of Inflammatory Breast Cancer Cells by Prostanoid Receptors EP3 and EP4
Fredika M. Robertson et al.
CANCER (2010)
Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
Naoki Terada et al.
CANCER RESEARCH (2010)
Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer
Rabindra N. Bhattacharjee et al.
CANCER SCIENCE (2010)
Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities
Xinrong Ma et al.
MOLECULAR CANCER RESEARCH (2010)
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
Namita Kundu et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
R. E. Harris
INFLAMMOPHARMACOLOGY (2009)
Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer
Xiao-Hua Zhang et al.
BMC CANCER (2008)
Cyclooxygenases, prostanoids, and tumor progression
Man-Tzu Wang et al.
CANCER AND METASTASIS REVIEWS (2007)
VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer
Vincent van Iterson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis
Caname Iwata et al.
CANCER RESEARCH (2007)
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells
A. V. Timoshenko et al.
BRITISH JOURNAL OF CANCER (2007)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer
N. L. P. Barnes et al.
BRITISH JOURNAL OF CANCER (2007)
EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway
Robert J. George et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism
Li Yang et al.
CANCER RESEARCH (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
AV Timoshenko et al.
BRITISH JOURNAL OF CANCER (2006)
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
XR Ma et al.
CANCER RESEARCH (2006)
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
RE Harris et al.
BMC CANCER (2006)
Tumor lymphangiogenesis in inflammatory breast carcinoma: A histomorphometric study
I Van der Auwera et al.
CLINICAL CANCER RESEARCH (2005)
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice
LR Howe et al.
CANCER RESEARCH (2005)
Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma
B Worden et al.
CANCER RESEARCH (2005)
The prostaglandin R2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia
SH Chang et al.
CANCER RESEARCH (2005)
COX-2 expression in DCIS:: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features
G Perrone et al.
HISTOPATHOLOGY (2005)
PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors
AV Timoshenko et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Lack of lymphangiogenesis during breast carcinogenesis
MM Vleugel et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells
AV Timoshenko et al.
EXPERIMENTAL CELL RESEARCH (2003)
Lymphangiogenesis and tumor metastasis
MS Pepper et al.
CELL AND TISSUE RESEARCH (2003)
Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells
K Kabashima et al.
NATURE MEDICINE (2003)
Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases
H Fujino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
C Costa et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
T Kawamori et al.
CARCINOGENESIS (2001)
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis
JG Rozic et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
CH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
分享论文
